CONCORD DRUGS
Back to Balance Sheet
|
CONCORD DRUGS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Liabilities | ₹65 Cr | ₹59 Cr | ₹58 Cr | ₹56 Cr |
What is the latest Total Liabilities ratio of CONCORD DRUGS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹65 Cr |
| Mar2024 | ₹59 Cr |
| Mar2023 | ₹58 Cr |
| Mar2022 | ₹56 Cr |
How is Total Liabilities of CONCORD DRUGS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹65 Cr | 10.77 | |
| Mar2024 | ₹59 Cr | 0.99 | |
| Mar2023 | ₹58 Cr | 3.16 | |
| Mar2022 | ₹56 Cr | - | |
Compare Total Liabilities of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹93.8 Cr | 1.4% | -6.6% | 12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | 1.4% |
-6.6% |
12.7% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses